Evidence map›Paper›PMID 39271652›Full record

ArticleNature communications2024

HIF-2α-dependent induction of miR-29a restrains T

Agnieszka K Czopik, Eóin N McNamee, Victoria Vaughn, Xiangsheng Huang, In Hyuk Bang, Trent Clark, Yanyu Wang, Wei Ruan, Tom Nguyen, Joanne C Masterson and 12 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Interplay between ischemia-reperfusion and metabolic reprogramming.Apoptosis : an international journal on programmed cell death · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Agnieszka K Czopik *Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA. Agnieszka.K.Czopik@uth.tmc.edu.ORCID 0009-0000-7179-7537
Eóin N McNamee *Mucosal Inflammation Program, University of Colorado Anschutz School of Medicine, Aurora, CO, USA.
Victoria VaughnDepartment of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Xiangsheng HuangDepartment of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
In Hyuk BangDepartment of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Trent ClarkDepartment of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Yanyu WangDepartment of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Wei RuanDepartment of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0002-2718-7923
Tom NguyenMucosal Inflammation Program, University of Colorado Anschutz School of Medicine, Aurora, CO, USA.ORCID 0000-0003-4222-4099
Joanne C MastersonMucosal Inflammation Program, University of Colorado Anschutz School of Medicine, Aurora, CO, USA.ORCID 0000-0002-8336-9879
Eunyoung TakDigestive Health Institute, Children's Hospital Colorado, Aurora, CO, USA.
Sandra FrankOrgan Protection Program, Department of Anesthesiology, University of Colorado - Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0002-1749-0339
Colm B CollinsMucosal Inflammation Program, University of Colorado Anschutz School of Medicine, Aurora, CO, USA.
Howard LiDivision of Pulmonary Sciences and Critical Care Medicine, School of Medicine, University of Colorado - Anschutz Medical Campus, Aurora, CO, USA.
Cristian Rodriguez-AguayoDepartmental of Experimental Therapeutics and Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-7880-7723
Gabriel Lopez-BeresteinDepartmental of Experimental Therapeutics and Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mark E GerichMucosal Inflammation Program, University of Colorado Anschutz School of Medicine, Aurora, CO, USA.
Glenn T FurutaMucosal Inflammation Program, University of Colorado Anschutz School of Medicine, Aurora, CO, USA.
Xiaoyi YuanDepartment of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0002-2898-6495
Anil K SoodDepartmental of Experimental Therapeutics and Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0003-4242-1762
Edwin F de ZoetenMucosal Inflammation Program, University of Colorado Anschutz School of Medicine, Aurora, CO, USA. Edwin.DeZoeten@childrenscolorado.org.ORCID 0000-0002-0946-9759
Holger K EltzschigDepartment of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0002-5676-6473

Funding

microRNA miR-147 Dampens Alveolar Epithelial Inflammation During ARDSR01HL154720 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ELTZSCHIG, HOLGER K. · 2021 to 2024
$2.2M
Targeting Myeloid Dependent MicroRNAs in Acute Respiratory Distress SyndromeR01HL155950 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Xiaoyi Yuan · 2022 to 2026
$2.0M
Targeting MicroRNA miR-122 for the Treatment of Perioperative Liver InjuryR01DK122796 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ELTZSCHIG, HOLGER K., JU, CYNTHIA · 2020 to 2023
$1.8M
microRNA-dependent regulation of intestinal T-cells²R01DK111856 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI DE ZOETEN, EDWIN FULCO · 2018 to 2022
$1.7M
MicroRNA Shuttling during Acute Respiratory Distress SyndromeR01HL133900 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ELTZSCHIG, HOLGER K. · 2017 to 2020
$1.5M
NHLBI NIH HHS R01 HL133900NHLBI NIH HHS R01 HL154720NHLBI NIH HHS R01 HL155950NIDDK NIH HHS R01 DK111856NIDDK NIH HHS R01 DK122796United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (CDMRP) HT94252310094
6 · The paper itself

Abstract

Metabolic imbalance leading to inflammatory hypoxia and stabilization of hypoxia-inducible transcription factors (HIFs) is a hallmark of inflammatory bowel diseases. We hypothesize that HIF could be stabilized in CD4

Indexed as

Basic Helix-Loop-Helix ProteinsColitisMicroRNAsTh1 CellsAnimalsCD4-Positive T-LymphocytesDisease Models, AnimalEndothelial PAS Domain-Containing Protein 1FemaleHumansMaleMiceMice, Inbred C57BLMice, KnockoutT-bet Transcription FactorT-Box Domain ProteinsBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1MicroRNAsMIRN29 microRNA, mouseT-bet Transcription FactorT-Box Domain Proteins

Identifiers

PMID39271652
PMCPMC11399416

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.